IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · IEX Real-Time Price · USD
1.190
+0.010 (0.85%)
At close: Mar 27, 2024, 4:00 PM
1.230
+0.040 (3.36%)
After-hours: Mar 27, 2024, 7:55 PM EDT

IceCure Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
5457107--
Market Cap Growth
--46.45%---
Enterprise Value
413482-8-6
PE Ratio
-1.58-3.36-10.77--
PS Ratio
18.5218.5125.76--
PB Ratio
3.652.253.96--
P/FCF Ratio
-1.70-3.76-8.11--
P/OCF Ratio
-1.76-3.99-8.46--
EV/Sales Ratio
14.1010.9419.79-2.03-3.41
EV/EBITDA Ratio
-0.74-2.05-8.531.921.17
EV/EBIT Ratio
-0.73-2.02-8.421.891.16
EV/FCF Ratio
-0.81-2.22-6.232.002.65
Debt / Equity Ratio
0.040.020.030.060.07
Debt / EBITDA Ratio
-0.04-0.04-0.09-0.08-0.05
Debt / FCF Ratio
-0.04-0.04-0.07-0.08-0.11
Quick Ratio
3.205.546.492.231.63
Current Ratio
4.036.497.542.581.93
Asset Turnover
0.120.120.200.44-
Interest Coverage
--70.04-56.87--
Return on Equity (ROE)
-77.40%-82.30%-60.70%-83.50%-
Return on Assets (ROA)
-63.00%-66.10%-46.50%-42.60%-
Return on Capital (ROIC)
-104.59%-64.33%-34.89%-69.26%-135.49%
Earnings Yield
-28.93%-29.74%-9.28%--
FCF Yield
-26.88%-26.59%-12.32%--
Buyback Yield / Dilution
-23.89%-29.66%-66.67%-25.75%-
Total Shareholder Return
-23.89%-29.66%-66.67%-25.75%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).